FABP5 drives obesity-induced hepatocellular carcinoma by promoting lipid peroxidation resistance and immunosuppression, while its inhibition induces ferroptosis and a pro-inflammatory tumor microenvironment, offering a potential therapeutic strategy. The gene discussed is FABP5; the disease is hepatocellular carcinoma.